XML 65 R56.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 4 Months Ended
Sep. 23, 2021
Mar. 31, 2022
Mar. 31, 2022
Dec. 31, 2012
Share-Based Compensation [Line Items]        
Unrecognized stock-based compensation expense related to stock options   $ 2.0 $ 2.0  
2017 Plan        
Share-Based Compensation [Line Items]        
Shares available for grant   2,000,000 2,000,000  
2012 Purchase Plan        
Share-Based Compensation [Line Items]        
Number of shares authorized       2,000,000
Number of additional shares authorized 2,000,000      
Maximum number of shares per participant per offering period 5,000      
Shares issued under the Plan     2,000,000  
Options and RSUs | Non-employee director        
Share-Based Compensation [Line Items]        
Service period for award vesting (in years)   1 year    
Stock options        
Share-Based Compensation [Line Items]        
Award expiration period (in years)   10 years    
Weighted-average period for recognition (in years)   1 year 9 months 18 days    
Stock options | President and Chief Executive Officer        
Share-Based Compensation [Line Items]        
Award expiration period (in years)   7 years    
RSUs        
Share-Based Compensation [Line Items]        
Service period for award vesting (in years)   4 years    
Unrecognized stock-based compensation expense related to RSUs   $ 90.8 $ 90.8  
Weighted-average period for recognition (in years)   2 years 8 months 12 days    
RSUs | Achievement levels based on EPS targets        
Share-Based Compensation [Line Items]        
Vesting weight (percent)   34.00%    
RSUs | Relative total stockholders return        
Share-Based Compensation [Line Items]        
Vesting weight (percent)   33.00%    
RSUs | Performance based on Nasdaq Healthcare Provider Index        
Share-Based Compensation [Line Items]        
Vesting weight (percent)   33.00%